Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. - Wikidata - awgldk - TriplyDB

Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial.

Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial.

http://www.wikidata.org/entity/Q46367878

about

Endoluminal stents for superficial femoral and popliteal artery occlusions in patients with lower limb peripheral artery disease Periprocedural antithrombotic therapy during various types of percutaneous cardiovascular interventions New developments in the clinical use of drug-coated balloon catheters in peripheral arterial disease Korean Guidelines for Interventional Recanalization of Lower Extremity Arteries Acute reductions in mechanical wall strain precede the formation of intimal hyperplasia in a murine model of arterial occlusive disease.Minimally invasive revascularization strategies for chronic lower limb ischemia.[PTA and stent placement distal to the superficial femoral artery]Current state of endovascular treatment of femoro-popliteal artery disease.Peripheral atherectomy: a critical review.Rupture and migration of an endovascular stent in the brachiocephalic trunk causing a vertebral steal syndrome.Antiplatelet and anticoagulant drugs in interventional radiology.Critical evaluation of stents in the peripheral arterial disease of the superficial femoral artery - focus on the paclitaxel eluting stent Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields.Percutaneous treatment of peripheral vascular disease: the role of diabetes and inflammation Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.Endovascular treatment of femoral-popliteal disease The primary patency and fracture rates of self-expandable nitinol stents placed in the popliteal arteries, especially in the P2 and P3 segments, in Korean patients Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions.First human trial of KW39 slotted-tube stents: for percutaneous coronary intervention Endovascular intervention for peripheral artery disease.Outcomes for clinical studies assessing drug and revascularization therapies for claudication and critical limb ischemia in peripheral artery disease Comparison of diamond-like carbon-coated nitinol stents with or without polyethylene glycol grafting and uncoated nitinol stents in a canine iliac artery model.Superficial femoral artery: current treatment options.The engineering of endovascular stent technology: a review.Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial Drug-eluting stents in the management of peripheral arterial disease Current endovascular therapy for lower extremity peripheral arterial disease: indications, outcomes and modalities.Delivery site of perivascular endothelial cell matrices determines control of stenosis in a porcine femoral stent model.Adventitial nab-rapamycin injection reduces porcine femoral artery luminal stenosis induced by balloon angioplasty via inhibition of medial proliferation and adventitial inflammation.Intravascular foreign bodies: danger of unretrieved fragmented medical devices.Local drug delivery for treatment of coronary and peripheral artery disease.Stent fracture in the coronary and peripheral arteries.Peripheral artery disease. Part 2: medical and endovascular treatment.Current state of diagnosis and management of critical limb ischemia.Drug-coated balloons for coronary and peripheral interventional procedures.Magnetically targeted delivery of therapeutic agents to injured blood vessels for prevention of in-stent restenosis.The current role of endovascular intervention in the management of diabetic peripheral arterial disease Endovascular treatment of critical ischemia in the diabetic foot: new thresholds, new anatomies.Drug-coated balloons and their place in treating peripheral arterial disease.Endovascular stents: a review of their use in peripheral arterial disease.

P2860

Q24244722-4ED71F15-CE31-47FA-8B31-29F7002F1AC5 Q26740181-0F123CA9-AE43-4230-8F9C-10230E066113 Q26740218-76344E23-063C-4054-AC32-DE1C37D81DB1 Q26801709-63A02C9E-A7E1-4730-8A5E-E59C939C6784 Q30399953-E1C0C2BC-5AE9-4F82-A886-64FA60D80DAD Q33236821-B0947E38-E606-42D7-899B-78F0A87F21E7 Q33260168-5882F595-FE6F-4B04-B637-6CC625BE19B1 Q33298566-27D0750E-5842-44B2-8B87-46880D2EFEA9 Q33307441-A97E4F57-6AFF-47A3-B874-C026C1D21CBE Q33313098-F7BB1C9A-589B-4E21-83E4-4993CCC6AF8C Q33395898-87FD5D3E-EE97-4996-A79A-9FC5D7C52C74 Q33710114-680AC7C8-980A-4F39-A078-BA676B2CED29 Q33929284-99EBA9DF-24AB-4902-9CAB-A0E61AF89FEF Q34018425-926D6AA3-0892-4444-8D59-4135345F6C95 Q34449178-5D8CCC6D-3F31-44BD-AD03-892F0FC3F355 Q34563744-25AB3BC3-104A-41AD-A5E2-D05B6EB0AA4A Q34642030-D8F6D521-6613-4B46-8DCD-D78BE05CB929 Q35009691-284F6A4E-9FC0-41F2-BA7B-E2C5BBD6C61E Q35594750-AE1C127D-2475-463E-8D1E-83712C821ABB Q35857220-85BF64B4-0AC3-4526-9091-5ED8CB80C847 Q35866198-B4412460-2292-4C1C-887A-04EA6E2F72E6 Q36325343-B127C6DF-301B-4986-B2EC-00EABB6DEE0C Q36401455-12EEEA7C-5AFC-49FC-9D72-0158C5D2FFDF Q36441888-17E53B0D-B736-4F48-A20A-7A0559E481F7 Q36774583-9C1B462F-7298-4D99-AD29-541A70C64EBD Q36835836-05C9E72D-D9B4-4380-8FED-8F4AF5F2FD67 Q36982443-ABAE1F5D-616F-4A85-86EC-7494FC20CA69 Q37456910-90C42CA7-5886-4EDF-9A12-132D0DB24F9D Q37463102-B0AF7A4E-6899-4D59-8B04-B3FB1F90054C Q37523440-63B76132-85EE-480F-9DCD-1F0BBE00B4F3 Q37765610-E1DD6BAC-71CF-488A-8FA4-155700533662 Q37784167-C85ABEF0-AD2C-4A67-81B6-9AE5798A9990 Q37889106-B312C5B0-9E89-416E-BE89-7EE87E916A21 Q37981977-0E98DE8D-1087-419D-9135-865EA772D090 Q38028877-B009CB40-6CE3-48A6-82D4-492DE7BE6F6C Q38034502-2760A542-A794-42F6-9CBA-FD9F17377DD2 Q38050775-A336FCCD-7519-401E-ADAC-2841017FB455 Q38058074-2D40382D-0E89-497C-9F3A-CF3470A6C9ED Q38070705-4A7B6FAC-D394-44C1-A04E-6112D3F05D95 Q38098451-F72CB3B9-60D3-4244-8B21-429093508F5E

P2860

Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial.

http://www.wikidata.org/entity/Q46367878

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Sirolimus-eluting versus bare ...... disease: the SIROCCO II trial.

@en

Sirolimus-eluting versus bare ...... disease: the SIROCCO II trial.

@nl

type

label

Sirolimus-eluting versus bare ...... disease: the SIROCCO II trial.

@en

Sirolimus-eluting versus bare ...... disease: the SIROCCO II trial.

@nl

prefLabel

Sirolimus-eluting versus bare ...... disease: the SIROCCO II trial.

@en

Sirolimus-eluting versus bare ...... disease: the SIROCCO II trial.

@nl

P1433

Q46367878-59FFC27C-BE1D-465E-AAF8-8E89D3C10D65

P1476

Q46367878-6BF3ED7D-F2A8-4E4B-B0D4-00387521C77B

P2093

Q46367878-06C8FAF0-CA4A-4808-A48A-094B57311B9F

Q46367878-1A6A8926-EB1E-49CA-8917-924307B18E93

Q46367878-1E045618-E3A1-42AB-9861-C4DA9C3F9AD9

Q46367878-4202B6D6-2F98-469E-B254-C844FD42F017

Q46367878-4982C04E-DE29-4DA8-BE09-FF3C052054DF

Q46367878-4E130DBD-A2C1-47E8-9BF2-CB5D2CDC1D06

Q46367878-72249E4C-3A67-40AC-B095-8D9E045E3D91

Q46367878-A1BAC2F1-38CE-47B3-A067-63B35D2EA3ED

Q46367878-A74BF70F-A2AE-4E91-A45C-F863610BDF0A

Q46367878-D27C7881-2F07-49A7-98BE-F54C060CF620

P304

Q46367878-170756ED-ED2B-4580-9050-0C358B5EB533

P31

Q46367878-66D316CB-C0F5-42C5-98A4-4771FB4F1B66

P356

Q46367878-7E5A411A-DBA1-4744-915D-B1F0023AC3B7

P433

Q46367878-305A5421-D849-4DC6-A755-7183354E2DA8

P478

Q46367878-81262694-7BC9-48BC-9455-69D5FB11D26D

P577

Q46367878-E00600B1-6E9E-4612-86F2-1CB6B9DE580F

P698

Q46367878-26AB5886-9349-4382-8C25-5B8463AC1BC2

P356

01.RVI.0000151260.74519.CA

P1433

Journal of Vascular and Interventional Radiology

P1476

Sirolimus-eluting versus bare ...... disease: the SIROCCO II trial.

@en

P2093

Alexander Tielbeek

http://www.w3.org/2001/XMLSchema#string

Alexandra Lansky

http://www.w3.org/2001/XMLSchema#string

Benjamin Wiesinger

http://www.w3.org/2001/XMLSchema#string

Catharina Mudde

http://www.w3.org/2001/XMLSchema#string

Dierk Scheinert

http://www.w3.org/2001/XMLSchema#string

Gunnar Tepe

http://www.w3.org/2001/XMLSchema#string

Hans Tielemans

http://www.w3.org/2001/XMLSchema#string

Jean P Bérégi

http://www.w3.org/2001/XMLSchema#string

Johannes Lammer

http://www.w3.org/2001/XMLSchema#string

John Anderson

http://www.w3.org/2001/XMLSchema#string

P304

331-338

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/01.RVI.0000151260.74519.CA

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2005-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15758128

http://www.w3.org/2001/XMLSchema#string